Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 749 Patent Reexam Terminated NIRC to follow--Fleeced,

Wasn't the 749 the original patent? All of the patents started out as one many years ago and the USPTO seperated it into several. I think that the 749 was the original. If you remember it another way please let me know. GL, ads

Share
New Message
Please login to post a reply